Strata Critical Medical (SRTA) grants 37,675 RSUs to director Reginald Love

Rhea-AI Filing Summary

Love Reginald reported acquisition or exercise transactions in this Form 4 filing.

Strata Critical Medical, Inc. reported that director Reginald Love received a grant of 37,675 Restricted Stock Units (RSUs) on July 30, 2026. The RSUs will be settled in Class A common stock and 100% vest on the date of the company's 2027 Annual Meeting of Stockholders. Following this equity award, Love's reported direct holdings total 151,572 shares of Class A common stock.

Insider Trade Summary

Net Buyer: 37,675 shares

Net Buy 1 txn

Insider Love Reginald

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A common stock, $0.0001 par value per share F1	37,675	$0.00	$0.00

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 151,572 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders.

Key Figures

RSUs granted: 37,675 RSUs Shares held after grant: 151,572 shares Reported grant price: $0.0000 per share +2 more

5 metrics

RSUs granted 37,675 RSUs Restricted Stock Units granted to director Reginald Love on July 30, 2026

Shares held after grant 151,572 shares Total direct Class A common stock holdings reported after the RSU grant

Reported grant price $0.0000 per share Per-share value field associated with the RSU grant

Vesting percentage 100% Portion of RSUs that vest on the date of the 2027 Annual Meeting of Stockholders

Vesting year 2027 All RSUs vest on the date of the company’s 2027 Annual Meeting of Stockholders

Key Terms

Restricted Stock Units, RSUs, Annual Meeting of Stockholders, Class A common stock

4 terms

Restricted Stock Units financial

"Represents a grant of Restricted Stock Units ("RSUs"), which will be settled"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"100% of the RSUs will become vested on the date of the Issuer's 2027"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Annual Meeting of Stockholders regulatory

"vested on the date of the Issuer's 2027 Annual Meeting of Stockholders"

Class A common stock financial

"settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/03/2026 - 04:07 PM Accepted by SEC EDGAR 08/03/2026 - 04:07 PM Learn about SEC filing dates

FAQ

What insider transaction did Strata Critical Medical (SRTA) report for Reginald Love?

Strata Critical Medical reported that director Reginald Love received a grant of 37,675 RSUs on July 30, 2026, which will be settled in shares of Class A common stock upon vesting.

What are the vesting terms of Reginald Love’s 37,675 RSUs at SRTA?

The filing states that 100% of the 37,675 RSUs granted to Reginald Love will vest on the date of Strata Critical Medical’s 2027 Annual Meeting of Stockholders, at which time they will settle in common shares.

How many Strata Critical Medical (SRTA) shares does Reginald Love hold after this RSU grant?

After the reported RSU grant, Reginald Love’s direct holdings total 151,572 shares of Strata Critical Medical Class A common stock, according to the Form 4 data.

Was Reginald Love’s SRTA RSU grant made under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not checked, meaning the reported RSU grant to Reginald Love was not affirmed as made under a Rule 10b5-1 trading plan.

What type of security was granted to Reginald Love by Strata Critical Medical (SRTA)?

Reginald Love received Restricted Stock Units (RSUs) that will be settled in Class A common stock of Strata Critical Medical once the units fully vest at the 2027 Annual Meeting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Love Reginald

(Last) (First) (Middle)

C/O STRATA CRITICAL MEDICAL, INC.

666 THIRD AVENUE, 25TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, $0.0001 par value per share	07/30/2026		A		37,675(1)	A	$0	151,572	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders.

Remarks:

	/s/ Melissa M. Tomkiel, as attorney-in-fact for Reginald Love	08/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)